inhibitor | Acetylcholinesterase inhibitor | Reverse engineering | Reverse Polish notation | reverse engineering | Selective serotonin reuptake inhibitor | Reverse Address Resolution Protocol | Enzyme inhibitor | enzyme inhibitor | The reverse of Truxton's Congressional Gold Medal | reverse psychology | Reverse Polish Notation | reverse Polish notation | Reverse phase protein lysate microarray | reverse osmosis | Reverse migration | Reverse logistics | Reverse Discourse | reverse | Metalloprotease inhibitor | Matrix metalloproteinase inhibitor | Inhibitor | Farnesyltransferase inhibitor | Falling in Reverse | COX-2 inhibitor | ALK inhibitor | ACE inhibitor |
Crofelemer (USAN, trade name Fulyzaq) is a drug under development for the treatment of diarrhea associated with anti-HIV drugs such as nucleoside analog reverse transcriptase inhibitors and protease inhibitors.